Joseph J. DeGeorge

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

Lutz Müller, Robert J. Mauthe, Christopher M. Riley et al. · Regulatory Toxicology and Pharmacology · 2006 · 461 citations

Pharmacy, Pharmaceutics, Toxicology +12

An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing

Frank D. Sistare, Daniel Morton, Carl L. Alden et al. · Toxicologic Pathology · 2011 · 152 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Carcinogenicity Testing and the Evaluation of Regulatory Requirements for Pharmaceuticals

Joseph F. Contrera, Abigail Jacobs, Joseph J. DeGeorge · Regulatory Toxicology and Pharmacology · 1997 · 124 citations

Pharmacy, Toxicology, Pharmaceutical Regulation +13

Arecoline‐Stimulated Brain Incorporation of Intravenously Administered Fatty Acids in Unanesthetized Rats

Joseph J. DeGeorge, Tadashi Nariai, Shingo Yamazaki et al. · Journal of Neurochemistry · 1991 · 118 citations

Medicine, Neurobiology, Pharmacology +12

Regulatory Considerations for Oligonucleotide Drugs: Updated Recommendations for Pharmacology and Toxicology Studies

Lauren E. Black, James G. Farrelly, JOY A. CAVAGNARO et al. · Antisense Research and Development · 1994 · 62 citations

Medicine, Pharmacology, Toxicology +17